Japan Health Panel Approves Merck's Oral COVID-19 Treatment

A Japanese health ministry panel recommended approval of the COVID-19 antiviral pill developed by Merck last week, part of plans by Prime Minister Fumio Kishida to roll out new treatments by year's end.
Reuters Health Information

source https://www.medscape.com/viewarticle/965561?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?